Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Glioma treatment may improve with new therapies and technologies.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

Monitoring for adverse effects in clinical treatments is crucial.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

S100A4 and NMIIA promote tumor growth in glioblastoma by enhancing blood vessel functions.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Transcutol® helps drugs penetrate the skin more effectively in various formulations.

Natural products can help overcome cancer drug resistance.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Minoxidil-coated microbubbles with sonication effectively enhance hair growth.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.